Atreca (BCEL) received a Notice of Allowance for its US patent application 16/792,115 titled "ANTIBODIES THAT BIND TUMOR TISSUE FOR DIAGNOSIS AND THERAPY" - Patent Grants
Tweet Send to a Friend
Atreca (NASDAQ: BCEL) received a Notice ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
